Publications by authors named "Martin Marciniak"

Claim this Profile
P
Preapproval Information Exchange: Perspectives of U.S. Population Health Decision Makers on Preferences for Early Engagement with Investigational Therapies.
Diana Brixner, Tatia C Woodward, Nik Seifter, Joseph Biskupiak, Martin Marciniak

J Manag Care Spec Pharm· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of the psychological impact of cancer-related symptoms on patients with non-small cell lung cancer.
Mark S Walker, Gerhardt M Pohl, Arthur C Houts, Gerson Peltz, Paul J E Miller, Martin Marciniak

Psychooncology· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective observational comparison of clinical outcomes between african-american and caucasian patients receiving second-line treatment with pemetrexed for advanced non-small-cell lung cancer.
Eduardo Pennella, Coleman K Obasaju, Gerhardt Pohl, Gerson Peltz, Allicia C Girvan, Martin Marciniak

Clin Lung Cancer· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does Type of Tumor Histology Impact Survival among Patients with Stage IIIB/IV Non-Small Cell Lung Cancer Treated with First-Line Doublet Chemotherapy?
Karen M Clements, Gerson Peltz, Douglas E Faries, Kathleen Lang, Joshua Nyambose, Martin D Marciniak

Chemother Res Pract· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Out-of-pocket drug costs and drug utilization patterns of postmenopausal Medicare beneficiaries with osteoporosis.
Leslie Jackson Conwell, Dominick Esposito, Susan Garavaglia, Eric S Meadows, Margaret Colby, Martin Marciniak

Am J Geriatr Pharmacother· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized phase II study of paclitaxel and bevacizumab with and without gemcitabine as first-line treatment for metastatic breast cancer.
Adam Brufsky, Karen Hoelzer, Thaddeus Beck, Robert Whorf, Mark Keaton, Martin D Marciniak

Clin Breast Cancer· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutropenia-related costs in patients treated with first-line chemotherapy for advanced non-small cell lung cancer.
Michael E Stokes, Catherine E Muehlenbein, Martin D Marciniak, Douglas E Faries, Saeed Motabar

J Manag Care Pharm· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Costs of first-line doublet chemotherapy and lifetime medical care in advanced non-small-cell lung cancer in the United States.
Kathleen Lang, Martin D Marciniak, Douglas Faries, Michael Stokes, Don Buesching

Value Health· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends and predictors of first-line chemotherapy use among elderly patients with advanced non-small cell lung cancer in the United States.
Kathleen Lang, Martin D Marciniak, Doug Faries, Michael Stokes, Don Buesching

Lung Cancer· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase III study of immediate compared with delayed docetaxel after front-line therapy with gemcitabine plus carboplatin in advanced non-small-cell lung cancer.
Panos M Fidias, Shaker R Dakhil, Alan P Lyss, David M Loesch, David M Waterhouse, Martin Marciniak

J Clin Oncol· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The cost of comorbid depression and pain for individuals diagnosed with generalized anxiety disorder.
Baojin Zhu, Zhongyun Zhao, Wenyu Ye, Martin D Marciniak, Ralph Swindle

J Nerv Ment Dis· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Duloxetine treatment for role functioning improvement in generalized anxiety disorder: three independent studies.
Jean Endicott, James M Russell, Joel Raskin, Michael J Detke, Janelle Erickson, Martin Marciniak

J Clin Psychiatry· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of effect size to determine optimal dose of duloxetine in major depressive disorder.
Yili L Pritchett, Martin D Marciniak, Patricia K Corey-Lisle, Richard A Berzon, Durisala Desaiah

J Psychiatr Res· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The cost of treating anxiety: the medical and demographic correlates that impact total medical costs.
Martin D Marciniak, Maureen J Lage, Eduardo Dunayevich, James M Russell, Lee Bowman

Depress Anxiety· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medical and productivity costs of anxiety disorders: case control study.
Martin Marciniak, Maureen J Lage, Ronald P Landbloom, Eduardo Dunayevich, Lee Bowman

Depress Anxiety· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The benefits of switching smoking cessation drugs to over-the-counter status.
Theodore E Keeler, Teh-wei Hu, Alison Keith, Richard Manning, Martin D Marciniak

Health Econ· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis